COSAN SA -ADR (CSAN) Fundamental Analysis & Valuation

NYSE:CSAN • US22113B1035

Current stock price

4.08 USD
+0.03 (+0.74%)
At close:
4.08 USD
0 (0%)
After Hours:

This CSAN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. CSAN Profitability Analysis

1.1 Basic Checks

  • In the past year CSAN has reported negative net income.
  • CSAN had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: CSAN reported negative net income in multiple years.
  • CSAN had a positive operating cash flow in each of the past 5 years.
CSAN Yearly Net Income VS EBIT VS OCF VS FCFCSAN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B -5B 10B

1.2 Ratios

  • CSAN has a Return On Assets of -7.20%. This is in the lower half of the industry: CSAN underperforms 69.11% of its industry peers.
  • The Return On Equity of CSAN (-183.29%) is worse than 76.42% of its industry peers.
  • CSAN has a better Return On Invested Capital (5.94%) than 60.98% of its industry peers.
  • CSAN had an Average Return On Invested Capital over the past 3 years of 5.03%. This is significantly below the industry average of 13.57%.
  • The last Return On Invested Capital (5.94%) for CSAN is above the 3 year average (5.03%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -7.2%
ROE -183.29%
ROIC 5.94%
ROA(3y)-4.36%
ROA(5y)-1.19%
ROE(3y)-88.16%
ROE(5y)-43.45%
ROIC(3y)5.03%
ROIC(5y)4.46%
CSAN Yearly ROA, ROE, ROICCSAN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50 -100 -150

1.3 Margins

  • CSAN's Operating Margin of 22.26% is amongst the best of the industry. CSAN outperforms 98.37% of its industry peers.
  • In the last couple of years the Operating Margin of CSAN has grown nicely.
  • The Gross Margin of CSAN (32.60%) is worse than 60.98% of its industry peers.
  • In the last couple of years the Gross Margin of CSAN has grown nicely.
Industry RankSector Rank
OM 22.26%
PM (TTM) N/A
GM 32.6%
OM growth 3Y13.92%
OM growth 5Y11.46%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y13.5%
GM growth 5Y3.58%
CSAN Yearly Profit, Operating, Gross MarginsCSAN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. CSAN Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CSAN is destroying value.
  • CSAN has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, CSAN has more shares outstanding
  • The debt/assets ratio for CSAN is higher compared to a year ago.
CSAN Yearly Shares OutstandingCSAN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M
CSAN Yearly Total Debt VS Total AssetsCSAN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50B 100B

2.2 Solvency

  • CSAN has an Altman-Z score of 0.73. This is a bad value and indicates that CSAN is not financially healthy and even has some risk of bankruptcy.
  • CSAN has a worse Altman-Z score (0.73) than 71.54% of its industry peers.
  • CSAN has a debt to FCF ratio of 15.47. This is a negative value and a sign of low solvency as CSAN would need 15.47 years to pay back of all of its debts.
  • With a Debt to FCF ratio value of 15.47, CSAN perfoms like the industry average, outperforming 48.78% of the companies in the same industry.
  • CSAN has a Debt/Equity ratio of 12.39. This is a high value indicating a heavy dependency on external financing.
  • With a Debt to Equity ratio value of 12.39, CSAN is not doing good in the industry: 79.67% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 12.39
Debt/FCF 15.47
Altman-Z 0.73
ROIC/WACC0.89
WACC6.69%
CSAN Yearly LT Debt VS Equity VS FCFCSAN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B

2.3 Liquidity

  • CSAN has a Current Ratio of 2.58. This indicates that CSAN is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Current ratio value of 2.58, CSAN belongs to the best of the industry, outperforming 87.80% of the companies in the same industry.
  • A Quick Ratio of 2.45 indicates that CSAN has no problem at all paying its short term obligations.
  • With an excellent Quick ratio value of 2.45, CSAN belongs to the best of the industry, outperforming 91.87% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.58
Quick Ratio 2.45
CSAN Yearly Current Assets VS Current LiabilitesCSAN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. CSAN Growth Analysis

3.1 Past

  • CSAN shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -9.45%.
  • CSAN shows a decrease in Revenue. In the last year, the revenue decreased by -8.04%.
  • The Revenue has been growing by 24.51% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-9.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%47.95%
Revenue 1Y (TTM)-8.04%
Revenue growth 3Y0.92%
Revenue growth 5Y24.51%
Sales Q2Q%-18.3%

3.2 Future

  • Based on estimates for the next years, CSAN will show a very strong growth in Earnings Per Share. The EPS will grow by 31.35% on average per year.
  • CSAN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.22% yearly.
EPS Next Y119.84%
EPS Next 2Y52.31%
EPS Next 3Y31.35%
EPS Next 5YN/A
Revenue Next Year4.56%
Revenue Next 2Y4.07%
Revenue Next 3Y3.58%
Revenue Next 5Y3.22%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CSAN Yearly Revenue VS EstimatesCSAN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50B 100B 150B
CSAN Yearly EPS VS EstimatesCSAN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 5 -5 -10 -15

More info and screens

Find the best growth stocksShow best growing peers

7

4. CSAN Valuation Analysis

4.1 Price/Earnings Ratio

  • CSAN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Based on the Price/Forward Earnings ratio of 5.82, the valuation of CSAN can be described as very cheap.
  • Based on the Price/Forward Earnings ratio, CSAN is valued cheaply inside the industry as 98.37% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 22.24, CSAN is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 5.82
CSAN Price Earnings VS Forward Price EarningsCSAN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, CSAN is valued cheaper than 91.06% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of CSAN indicates a rather cheap valuation: CSAN is cheaper than 97.56% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 4.34
EV/EBITDA 4.49
CSAN Per share dataCSAN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4 6 8

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • CSAN's earnings are expected to grow with 31.35% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y52.31%
EPS Next 3Y31.35%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. CSAN Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 2.44%, CSAN has a reasonable but not impressive dividend return.
  • CSAN's Dividend Yield is a higher than the industry average which is at 3.36.
  • Compared to an average S&P500 Dividend Yield of 1.81, CSAN pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 2.44%

5.2 History

  • The dividend of CSAN is nicely growing with an annual growth rate of 13.34%!
  • CSAN has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)13.34%
Div Incr Years0
Div Non Decr Years0
CSAN Yearly Dividends per shareCSAN Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 0.5 1

5.3 Sustainability

  • CSAN has negative earnings and hence a negative payout ratio. The dividend may be in danger.
  • The dividend of CSAN is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-27.7%
EPS Next 2Y52.31%
EPS Next 3Y31.35%
CSAN Yearly Income VS Free CF VS DividendCSAN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B -5B

More info and screens

Find the best dividend stocksShow peers with best dividend

CSAN Fundamentals: All Metrics, Ratios and Statistics

COSAN SA -ADR

NYSE:CSAN (4/24/2026, 8:04:00 PM)

After market: 4.08 0 (0%)

4.08

+0.03 (+0.74%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)03-08
Earnings (Next)05-14
Inst Owners21.71%
Inst Owner Change0.08%
Ins OwnersN/A
Ins Owner Change0%
Market Cap4.00B
Revenue(TTM)40.42B
Net Income(TTM)-9.72B
Analysts76.25
Price Target6.1 (49.51%)
Short Float %0.54%
Short Ratio1.37
Dividend
Industry RankSector Rank
Dividend Yield 2.44%
Yearly Dividend0.84
Dividend Growth(5Y)13.34%
DP-27.7%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-1816.85%
Min EPS beat(2)-3315.17%
Max EPS beat(2)-318.54%
EPS beat(4)0
Avg EPS beat(4)-1314.47%
Min EPS beat(4)-3315.17%
Max EPS beat(4)-318.54%
EPS beat(8)0
Avg EPS beat(8)-857.58%
EPS beat(12)1
Avg EPS beat(12)-575.78%
EPS beat(16)2
Avg EPS beat(16)-430.38%
Revenue beat(2)0
Avg Revenue beat(2)-75.49%
Min Revenue beat(2)-76.24%
Max Revenue beat(2)-74.75%
Revenue beat(4)0
Avg Revenue beat(4)-75.34%
Min Revenue beat(4)-76.92%
Max Revenue beat(4)-73.47%
Revenue beat(8)0
Avg Revenue beat(8)-74.14%
Revenue beat(12)0
Avg Revenue beat(12)-51.79%
Revenue beat(16)0
Avg Revenue beat(16)-57.5%
PT rev (1m)27%
PT rev (3m)26.43%
EPS NQ rev (1m)-97.23%
EPS NQ rev (3m)-93.33%
EPS NY rev (1m)5.72%
EPS NY rev (3m)133.8%
Revenue NQ rev (1m)7.36%
Revenue NQ rev (3m)7.36%
Revenue NY rev (1m)2.39%
Revenue NY rev (3m)4.27%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 5.82
P/S 0.49
P/FCF 4.34
P/OCF 1.52
P/B 3.74
P/tB N/A
EV/EBITDA 4.49
EPS(TTM)-3.53
EYN/A
EPS(NY)0.7
Fwd EY17.18%
FCF(TTM)0.94
FCFY23.02%
OCF(TTM)2.68
OCFY65.66%
SpS8.31
BVpS1.09
TBVpS-4.4
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -7.2%
ROE -183.29%
ROCE 7.52%
ROIC 5.94%
ROICexc 7.92%
ROICexgc 11.28%
OM 22.26%
PM (TTM) N/A
GM 32.6%
FCFM 11.3%
ROA(3y)-4.36%
ROA(5y)-1.19%
ROE(3y)-88.16%
ROE(5y)-43.45%
ROIC(3y)5.03%
ROIC(5y)4.46%
ROICexc(3y)6.25%
ROICexc(5y)5.51%
ROICexgc(3y)8.47%
ROICexgc(5y)7.42%
ROCE(3y)6.37%
ROCE(5y)5.64%
ROICexgc growth 3Y24.86%
ROICexgc growth 5Y-1.13%
ROICexc growth 3Y20.32%
ROICexc growth 5Y4.39%
OM growth 3Y13.92%
OM growth 5Y11.46%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y13.5%
GM growth 5Y3.58%
F-Score5
Asset Turnover0.3
Health
Industry RankSector Rank
Debt/Equity 12.39
Debt/FCF 15.47
Debt/EBITDA 5.1
Cap/Depr 217.43%
Cap/Sales 20.93%
Interest Coverage 1.74
Cash Conversion 101.08%
Profit Quality N/A
Current Ratio 2.58
Quick Ratio 2.45
Altman-Z 0.73
F-Score5
WACC6.69%
ROIC/WACC0.89
Cap/Depr(3y)202.18%
Cap/Depr(5y)187.98%
Cap/Sales(3y)18.22%
Cap/Sales(5y)16.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-9.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%47.95%
EPS Next Y119.84%
EPS Next 2Y52.31%
EPS Next 3Y31.35%
EPS Next 5YN/A
Revenue 1Y (TTM)-8.04%
Revenue growth 3Y0.92%
Revenue growth 5Y24.51%
Sales Q2Q%-18.3%
Revenue Next Year4.56%
Revenue Next 2Y4.07%
Revenue Next 3Y3.58%
Revenue Next 5Y3.22%
EBIT growth 1Y40.3%
EBIT growth 3Y14.96%
EBIT growth 5Y38.78%
EBIT Next Year111.26%
EBIT Next 3Y31.23%
EBIT Next 5Y16.63%
FCF growth 1Y-12.75%
FCF growth 3Y-5.67%
FCF growth 5Y33.17%
OCF growth 1Y-0.42%
OCF growth 3Y9.32%
OCF growth 5Y43.47%

COSAN SA -ADR / CSAN Fundamental Analysis FAQ

What is the ChartMill fundamental rating of COSAN SA -ADR (CSAN) stock?

ChartMill assigns a fundamental rating of 5 / 10 to CSAN.


What is the valuation status for CSAN stock?

ChartMill assigns a valuation rating of 7 / 10 to COSAN SA -ADR (CSAN). This can be considered as Undervalued.


What is the profitability of CSAN stock?

COSAN SA -ADR (CSAN) has a profitability rating of 4 / 10.


Can you provide the dividend sustainability for CSAN stock?

The dividend rating of COSAN SA -ADR (CSAN) is 5 / 10 and the dividend payout ratio is -27.7%.